shakedown.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A community for live music fans with roots in the jam scene. Shakedown Social is run by a team of volunteers (led by @clifff and @sethadam1) and funded by donations.

Administered by:

Server stats:

289
active users

#LongCovid

83 posts68 participants16 posts today

“Wake Up and Smell the C*VID: An evening without Eric Bogosian”: new play takes aim at NYC mask ban and more

thecanary.co/global/world-news

"As New York State’s budget deadline looms, so too does the specter of a proposed mask ban …"

"Wake Up and Smell the C*VID isn’t a typical play—it’s an intervention. A rupture. A refusal.

It refuses the erasure of an ongoing mass disabling event."

Canary · “Wake Up and Smell the C*VID: An evening without Eric Bogosian”: new play takes aim at NYC mask ban and more“Wake Up and Smell the C*VID: An evening without Eric Bogosian”: new play takes aim at NYC mask ban and more from Canary on 31 March 2025

#COVID19 Reinfections are more like to lead to #LongCOVID in kids:

STUDY: Compared to the first infection, a second infection was associated with higher risk of:

- 2.08x overall PASC diagnosis
- 3.60x myocarditis
- 2.28x thrombophlebitis and thromboembolism
- 1.96x heart disease
- 1.89x acute kidney injury
- 1.59x arrhythmias
- 1.56x abnormal liver enzyme
-1.50x fatigue and malaise
-1.35x postural orthostatic tachycardia syndromes
- 1.32x cognitive functions

medrxiv.org/content/10.1101/20

medRxiv · Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort StudyIMPORTANCE Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population. OBJECTIVE To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used data from the RECOVER consortium comprising 40 children's hospitals and health institutions in U.S. between January 2022 and October 2023. EXPOSURES A second SARS-CoV-2 infection, confirmed by a positive polymerase-chain-reaction (PCR) or antigen tests, or a diagnose of COVID-19, occurring at least 60 days after the initial infection, compared to the initial infection. MAIN OUTCOMES AND MEASURES PASC was identified using two approaches: (1) the ICD-10-CM diagnosis code U09.9 and (2) a symptom-based definition including 24 physician-identified symptoms and conditions. Absolute risks of incident PASC were reported, and relative risks (RRs) were calculated by comparing the second infection episode with the first infection episode groups using a modified Poisson regression model, adjusting for demographic, clinical, and healthcare utilization factors through exact matching and propensity scoring matching. RESULTS A total of 465,717 individuals under 21 years old (mean [SD] age 8.17 [6.58] years; 52% male) were included. Compared to the first infection, a second infection was associated with significantly increased risk of an overall PASC diagnosis (RR, 2.08; 95% confidence interval [CI], 1.68-2.59), and with many specific conditions including: myocarditis (RR, 3.60; 95% CI, 1.46-8.86); changes in taste and smell (RR, 2.83; 95% CI, 1.41-5.67); thrombophlebitis and thromboembolism (RR, 2.28; 95% CI, 1.71-3.04); heart disease (RR, 1.96; 95% CI, 1.69 to 2.28); acute kidney injury (RR, 1.90; 95% CI, 1.38 to 2.61); fluid and electrolyte (RR, 1.89; 95% CI, 1.62 to 2.20); generalized pain (RR, 1.70; 95% CI, 1.48 to 1.95); arrhythmias (RR, 1.59; 95% CI, 1.45-1.74); abnormal liver enzyme (RR, 1.56; 95% CI, 1.24 to 1.96); fatigue and malaise (RR, 1.50; 95% CI, 1.38 to 1.64); musculoskeletal pain (RR, 1.45; 95% CI, 1.37 to 1.54); abdominal pain (RR, 1.42; 95% CI, 1.34 to 1.50); postural orthostatic tachycardia syndromes (POTS)/dysautonomia (RR, 1.35; 95% CI, 1.20 to 1.51); cognitive functions (RR, 1.32; 95% CI, 1.15 to 1.50); and respiratory signs and symptoms (RR, 1.29; 95% CI, 1.25 to 1.33). The risks were consistent across various organ systems, including cardiovascular, respiratory, gastrointestinal, neurological, and musculoskeletal systems. CONCLUSIONS AND RELEVANCE Children and adolescents face significantly higher risk of various PASC outcomes after reinfection with SARS-CoV-2. These findings suggest a cumulative risk of PASC and highlight the urgent need for targeted prevention strategies to reduce reinfections, which includes an increased emphasis on initial or re-vaccination of children. ### Competing Interest Statement Dr. Jhaveri is a consultant for AstraZeneca, Seqirus, Gilead, Sanofi; receives an editorial stipend from the Pediatric Infectious Diseases Society; research support from GSK; and royalties from Up To Date/Wolters Kluwer. All other co-authors have no conflicts of interest to report. ### Funding Statement This research was funded by the National Institutes of Health (NIH) Agreement OT2HL161847-01 as part of the Researching COVID to Enhance Recovery (RECOVER) program of research. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethnics committee/IRB of University of Pennsylvania waived ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present study are available upon reasonable request.

Apparently, I need to order my repeat meds "at least 5 (working?) days before they are due." The GP needs 48 hours to do their bit and then the pharmacy need 48 hours to do theirs.

Fine.

But if I order 8 (calendar) days in advance, that's too early, and they won't pass it to the pharmacy until the day I should start taking them.

To avoid stockpiling.

So I'm now thinking about how to create a stockpile.

To avoid withdrawal.

La mitad de las infecciones de COVID son asintomáticas, lo tienes y no lo sabes
Mínimo el 10% de toda forma de infección acaba en LONG COVID, una enfermedad nueva, la mayoría de los médicos no te creen y usar su autoridad como violencia, las personas pobres y oprimidas son las más afectadas por esta eugenesia
Las vacunas no frenan ni la transmisión, ni la infección, ni el desarrollo de LONG COVID. las vacunas no están siendo actualizadas porque no paran de haber nuevas variantes por la negligencia del estado y la falta de mascarilla colectiva
#MaskUp #WearAMask #CovidRealist #CovidIsAirbone

#LlevaMascarilla #RealistaCovid #CovidSonAerosoles #birdflu #gripeaviar #LongCovid
10 Acciones para la Solidaridad durante la Pandemia
Escrito por @ps4.future
Mientras las instituciones capitalistas producen enfermedades y muerte masivas, no debemos abandonarnos entre nosotros. Juntos, tenemos el poder de dar forma a nuestras comunidades. Para hacerlo, debemos priorizar la salud y la seguridad de todas nuestras personas comprometiéndonos con estas 10 acciones:
1. USAR MASCARILLA: de alta calidad y bien ajustadas.
2. LIMPIAR EL AIRE: con purificadores de aire, abriendo ventanas
3. PRUEBAS FRECUENTES: de calidad PCR cuando sea posible. Aíslate de los demás en tu hogar y comunidad si das positivo o estás enfermo.
4. PLAN CAPAS.
5. COMPARTIR HERRAMIENTAS
6. CAMBIAR LA NARRATIVA: Utiliza un lenguaje intencional para promover la seguridad del COVID-19 y combatir la desinformación, minimización y negación en tus relaciones y comunidades.
7. EXIGIR SEGURIDAD.
8. PROTEGER ESPACIOS PÚBLICOS: Exige requisitos rigurosos y sólidos de seguridad COVID-19. Boicotea a aquellos que no los implementen.
9. EXIGIR PROTECCIÓN GUBERNAMENTAL.
10. ACTUAR EN SOLIDARIDAD: Prioriza tu compromiso con la liberación, lucha contra todos los sistemas de opresión y apoya a grupos que luchan por futuros justos.

Hey! Are you in the USA? Do you (or someone you know) have any of:

  • hypersomnia
  • complex sleep disturbances
  • postural orthostatic tachycardia syndrome, or POTS

which started or worsened after a bout of acute COVID-19?

Trials are open for treatments for these symptoms!

Those interested in participating in the trials can contact the clinic for screening to see if they are eligible. The team can be reached via email at covidtrialsuva@uvahealth.org, or by phone at 434-243-4008 or toll-free at 855-882-5334.

and they seem like good folks:

“We see patients coming in who are frustrated because they look fairly normal, but they cannot fully function and are not being believed,” she said. “So, for those people, I want to say this is truly a disease and you are not imagining anything.”

While UVA is in Virginia the article suggests it is a USA-wide national study.

news.virginia.edu/content/uva-

Illustration of a germ with a clock inside of it
UVA Today · UVA Health Takes Aim at Long COVID in Two National Clinical TrialsAn estimated 50 million Americans may be living with symptoms of varying severity.

The administration’s research funding and DEI cuts present an existential threat to regional public universities like Southern Illinois University, the economic backbone of the conservative rural region it serves.

propublica.org/article/regiona
#LongCovid #Holidays #Christmas #AdoptAFamily

ProPublicaA University, a Rural Town and Their Fight to Survive Trump’s War on Higher Education
More from ProPublica